NCT01745224终止不适用
Revlite Laser System Compared to the Candela Alex TriVantage System Refractory Mixed Type Melasma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 4
- 试验地点
- 1
- 主要终点
- Changes in Melasma Determined by Physician
研究概览
简要总结
This proof of concept study will be conducted to assess the aesthetic improvement in refractory mixed type melasma in subjects treated with two FDA 510K approved devices: Q Switched Nd: YAG Laser vs. Alex TriVantage
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Device Feasibility
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects with Fitzpatrick Skin Type III-VI
- •Subjects with mixed (epidermal and dermal) type melasma diagnosed by Wood's Lamp.
- •Subjects who are over the age of 18 years of age
- •The subject is willing and able to comply with study instructions and return to the clinic for required visits.
- •The subject's melasma has persisted for greater than 6 months and has failed to respond to conventional treatment with hydroquinone cream or other topical lightening agents.
排除标准
- •The subject is female and pregnant, has been pregnant within the last 3 months, is currently breast feeding or planning a pregnancy during the study period.
- •The subject has a history of cutaneous photosensitization, porphyria, and hypersensitivity to porphyrins or photodermatosis.
- •The subject has any skin pathology or condition that could interfere with the evaluation or requires the use of interfering topical or systemic therapy.
- •The subject has an uncorrected coagulation defect or is currently using anti-coagulation medication (including but not limited to heavy aspirin therapy).
- •The subject has any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in this research study.
- •The subject is currently enrolled in an investigational drug or device trial, or has received an investigational drug or been treated with an investigational device within 30 days prior to entering this study.
- •The subject has used photosensitizing drugs (e.g., Declomycin, sulfa antibiotics, phenothiazines, etc.) within a timeframe where photosensitization from these drugs may still be present.
- •The subject has the need to be exposed to artificial tanning devices or excessive sunlight during the trial.
- •The subject has had prior treatment with parenteral gold therapy (gold sodium thiomalate).
- •The subject has Diabetes Type 1 or
- •The subject has a sensitivity to hydroquinone or Retin-A.
- •The subject has evidence of a compromised immune system or hepatitis.
- •Has had microdermabrasion in past 3 months, other laser or Intense Pulsed Light treatment or chemical peels to the face in past 6 months, injectable fillers, topical retinoids, over-the-counter anti-aging products past 2 weeks.
- •Has a history of keloids or hypertrophic scarring
- •Has permanent make-up and/or is unwilling to refrain from using semi-permanent cosmetics during study
结局指标
主要结局
Changes in Melasma Determined by Physician
时间窗: 3 months post last treatment
The Global Aesthetic Improvement scale was used to determine the amount of improvement. This scale ranges from 1 to 5, where 1 is very much improved, 2 is much improved, 3 is improved, 4 is no change, and 5 is worsened.
次要结局
- Universal Pain Scale for Subject Tolerability(3 months post last treatment)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Picosure Alexandrite Laser and Revlite Nd:Yag Laser for the Treatment of Unwanted TattoosUnwanted TattoosNCT02110121Cynosure, Inc.63
已完成
不适用
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment StudyCataractAphakiaNCT05202808RxSight, Inc.500
已完成
不适用
Use of Laser Speckle to Study Post Occlusive Reactive Hyperhemia in Healthy SubjectsMicrocirculationNCT01169974University Hospital, Angers41
已完成
1 期
Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification SystemNeoplasmNCT00026871National Cancer Institute (NCI)20
已完成
不适用
A study of Thulium RevoLix laser usage for surgery to remove the tonsilsRecurrent or chronic tonsillitisRespiratoryISRCTN16280803Yerevan State Medical University12